MovDisordV3, PubMed, Corpus, bibRecord, 004F95

Early dopamine agonist therapy in Parkinson's disease.

Identifieur interne : 004F95 ( PubMed/Corpus ); précédent : 004F94; suivant : 004F96

Early dopamine agonist therapy in Parkinson's disease.

Auteurs : U K Rinne

Source :

Movement disorders : official journal of the Movement Disorder Society [ 0885-3185 ] ; 1989.

RBID : pubmed:2566915

English descriptors

KwdEn :
- Antiparkinson Agents (administration & dosage), Brain (drug effects), Bromocriptine (administration & dosage), Dopamine Agents (administration & dosage), Drug Therapy, Combination, Humans, Levodopa (administration & dosage), Lisuride (administration & dosage), Parkinson Disease (drug therapy), Pergolide (administration & dosage), Receptors, Dopamine (drug effects).
MESH :
- chemical , administration & dosage : Antiparkinson Agents, Bromocriptine, Dopamine Agents, Levodopa, Lisuride, Pergolide.
- drug effects : Brain, Receptors, Dopamine.
- drug therapy : Parkinson Disease.
- Drug Therapy, Combination, Humans.

PubMed: 2566915

Links to Exploration step

pubmed:2566915

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Early dopamine agonist therapy in Parkinson's disease.</title>
<author><name sortKey="Rinne, U K" sort="Rinne, U K" uniqKey="Rinne U" first="U K" last="Rinne">U K Rinne</name>
<affiliation><nlm:affiliation>Department of Neurology, University of Turku, Finland.</nlm:affiliation>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="1989">1989</date>
<idno type="RBID">pubmed:2566915</idno>
<idno type="pmid">2566915</idno>
<idno type="wicri:Area/PubMed/Corpus">004F95</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Early dopamine agonist therapy in Parkinson's disease.</title>
<author><name sortKey="Rinne, U K" sort="Rinne, U K" uniqKey="Rinne U" first="U K" last="Rinne">U K Rinne</name>
<affiliation><nlm:affiliation>Department of Neurology, University of Turku, Finland.</nlm:affiliation>
</affiliation>
</author>
</analytic>
<series><title level="j">Movement disorders : official journal of the Movement Disorder Society</title>
<idno type="ISSN">0885-3185</idno>
<imprint><date when="1989" type="published">1989</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Antiparkinson Agents (administration & dosage)</term>
<term>Brain (drug effects)</term>
<term>Bromocriptine (administration & dosage)</term>
<term>Dopamine Agents (administration & dosage)</term>
<term>Drug Therapy, Combination</term>
<term>Humans</term>
<term>Levodopa (administration & dosage)</term>
<term>Lisuride (administration & dosage)</term>
<term>Parkinson Disease (drug therapy)</term>
<term>Pergolide (administration & dosage)</term>
<term>Receptors, Dopamine (drug effects)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Antiparkinson Agents</term>
<term>Bromocriptine</term>
<term>Dopamine Agents</term>
<term>Levodopa</term>
<term>Lisuride</term>
<term>Pergolide</term>
</keywords>
<keywords scheme="MESH" qualifier="drug effects" xml:lang="en"><term>Brain</term>
<term>Receptors, Dopamine</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Drug Therapy, Combination</term>
<term>Humans</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
</TEI>
<pubmed><MedlineCitation Owner="NLM" Status="MEDLINE"><PMID Version="1">2566915</PMID>
<DateCreated><Year>1989</Year>
<Month>06</Month>
<Day>26</Day>
</DateCreated>
<DateCompleted><Year>1989</Year>
<Month>06</Month>
<Day>26</Day>
</DateCompleted>
<DateRevised><Year>2013</Year>
<Month>11</Month>
<Day>21</Day>
</DateRevised>
<Article PubModel="Print"><Journal><ISSN IssnType="Print">0885-3185</ISSN>
<JournalIssue CitedMedium="Print"><Volume>4 Suppl 1</Volume>
<PubDate><Year>1989</Year>
</PubDate>
</JournalIssue>
<Title>Movement disorders : official journal of the Movement Disorder Society</Title>
<ISOAbbreviation>Mov. Disord.</ISOAbbreviation>
</Journal>
<ArticleTitle>Early dopamine agonist therapy in Parkinson's disease.</ArticleTitle>
<Pagination><MedlinePgn>S86-94</MedlinePgn>
</Pagination>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Rinne</LastName>
<ForeName>U K</ForeName>
<Initials>UK</Initials>
<AffiliationInfo><Affiliation>Department of Neurology, University of Turku, Finland.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo><Country>UNITED STATES</Country>
<MedlineTA>Mov Disord</MedlineTA>
<NlmUniqueID>8610688</NlmUniqueID>
<ISSNLinking>0885-3185</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000978">Antiparkinson Agents</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D015259">Dopamine Agents</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D011954">Receptors, Dopamine</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>24MJ822NZ9</RegistryNumber>
<NameOfSubstance UI="D010479">Pergolide</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>3A64E3G5ZO</RegistryNumber>
<NameOfSubstance UI="D001971">Bromocriptine</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>46627O600J</RegistryNumber>
<NameOfSubstance UI="D007980">Levodopa</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>E0QN3D755O</RegistryNumber>
<NameOfSubstance UI="D008090">Lisuride</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName MajorTopicYN="N" UI="D000978">Antiparkinson Agents</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000008">administration & dosage</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D001921">Brain</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000187">drug effects</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D001971">Bromocriptine</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000008">administration & dosage</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D015259">Dopamine Agents</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000008">administration & dosage</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D004359">Drug Therapy, Combination</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D007980">Levodopa</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000008">administration & dosage</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D008090">Lisuride</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000008">administration & dosage</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D010300">Parkinson Disease</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000188">drug therapy</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D010479">Pergolide</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000008">administration & dosage</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D011954">Receptors, Dopamine</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000187">drug effects</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1989</Year>
<Month>1</Month>
<Day>1</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>1989</Year>
<Month>1</Month>
<Day>1</Day>
<Hour>0</Hour>
<Minute>1</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>1989</Year>
<Month>1</Month>
<Day>1</Day>
<Hour>0</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">2566915</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/PubMed/Corpus

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 004F95 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 004F95 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    PubMed
   |étape=   Corpus
   |type=    RBID
   |clé=     pubmed:2566915
   |texte=   Early dopamine agonist therapy in Parkinson's disease.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i   -Sk "pubmed:2566915" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd   \
       | NlmPubMed2Wicri -a MovDisordV3

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024

	Movement Disorders (revue)
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Movement Disorders (revue)

Early dopamine agonist therapy in Parkinson's disease.

Early dopamine agonist therapy in Parkinson's disease.

Source :

English descriptors

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki